Susman Robert Graham 4
4 · Immunovant, Inc. · Filed May 5, 2025
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Susman Robert Graham
Director
Transactions
- Award
Common Stock
2025-05-01+25,016→ 25,016 total - Award
Stock Option (Right to Buy)
2025-05-01+35,234→ 35,234 totalExercise: $15.90Exp: 2035-05-01→ Common Stock (35,234 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]These options were granted pursuant to the Plan. The shares underlying the options will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date.